Overview

Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease

Status:
Withdrawn
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether once-weekly prozac therapy leads to reduction in depression in patients requiring kidney dialysis.
Phase:
Phase 4
Details
Lead Sponsor:
Creighton University
Treatments:
Fluoxetine